Data / Drug companies / Strides Pharma Inc.
Strides Pharma Inc.: 23 products in the FDA NDC directory, labeler code 42543
Strides Pharma Inc. (labeler code 42543) lists 23 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 23 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on February 28, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42543
- Products in commercial distribution
- 23
- Packages
- 51
- Finished drugs by generic name
- 10
- Prescription products
- 23
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Flagged as original packager
- 23 of 23 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 31, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 23 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 23 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Buspirone hydrochloride | 5 | 50 |
| Potassium citrate | 3 | 17 |
| Hydrocortisone | 3 | 171 |
| Fluoxetine hydrochloride | 3 | 44 |
| Amantadine hydrochloride | 2 | 32 |
| Clopidogrel | 2 | 13 |
| Mycophenolate mofetil | 2 | 37 |
| Carisoprodol | 1 | 28 |
| Emtricitabine and tenofovir disoproxil fumarate | 1 | 28 |
| Levocetirizine dihydrochloride | 1 | 52 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 17 | 73.9% |
| Capsule | 5 | 21.7% |
| Tablet, film coated | 1 | 4.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mycophenolate mofetil | 42543-989 | Tablet, film coated | Generic drugs (ANDA) | February 28, 2025 |
| Mycophenolate mofetil | 42543-988 | Capsule | Generic drugs (ANDA) | February 28, 2025 |
| Hydrocortisone | 42543-972 | Tablet | Generic drugs (ANDA) | December 22, 2021 |
| Hydrocortisone | 42543-971 | Tablet | Generic drugs (ANDA) | December 22, 2021 |
| Hydrocortisone | 42543-970 | Tablet | Generic drugs (ANDA) | December 22, 2021 |
| Buspirone Hydrochloride | 42543-787 | Tablet | Generic drugs (ANDA) | April 1, 2021 |
| Buspirone Hydrochloride | 42543-744 | Tablet | Generic drugs (ANDA) | April 1, 2021 |
| Buspirone Hydrochloride | 42543-743 | Tablet | Generic drugs (ANDA) | April 1, 2021 |
| Buspirone Hydrochloride | 42543-742 | Tablet | Generic drugs (ANDA) | April 1, 2021 |
| Buspirone Hydrochloride | 42543-741 | Tablet | Generic drugs (ANDA) | April 1, 2021 |
| Emtricitabine and Tenofovir Disoproxil Fumarate | 42543-719 | Tablet | Generic drugs (ANDA) | March 30, 2021 |
| Potassium citrate extended release | 42543-408 | Tablet | Generic drugs (ANDA) | November 1, 2017 |
| Potassium citrate extended release | 42543-407 | Tablet | Generic drugs (ANDA) | November 1, 2017 |
| Potassium citrate extended release | 42543-406 | Tablet | Generic drugs (ANDA) | November 1, 2017 |
| Amantadine Hydrochloride | 42543-497 | Tablet | Generic drugs (ANDA) | August 4, 2017 |
| Amantadine Hydrochloride | 42543-493 | Capsule | Generic drugs (ANDA) | July 31, 2017 |
| Fluoxetine | 42543-727 | Capsule | Generic drugs (ANDA) | March 16, 2015 |
| Fluoxetine | 42543-726 | Capsule | Generic drugs (ANDA) | March 16, 2015 |
| Fluoxetine | 42543-725 | Capsule | Generic drugs (ANDA) | March 16, 2015 |
| Clopidogrel | 42543-714 | Tablet | Generic drugs (ANDA) | November 1, 2014 |
| Clopidogrel | 42543-713 | Tablet | Generic drugs (ANDA) | November 1, 2014 |
| Levocetirizine dihydrochloride | 42543-712 | Tablet | Generic drugs (ANDA) | October 27, 2014 |
| Carisoprodol | 42543-700 | Tablet | Generic drugs (ANDA) | July 31, 2014 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.